Acceleron Pharma (XLRN) Misses Q3 EPS by 2c

November 3, 2016 5:01 PM EDT
Get Alerts XLRN Hot Sheet
Trade XLRN Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Acceleron Pharma (NASDAQ: XLRN) reported Q3 EPS of ($0.55), $0.02 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $3 million versus the consensus estimate of $4.08 million.

For earnings history and earnings-related data on Acceleron Pharma (XLRN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment